Literature DB >> 25438200

The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis.

Aurelija Abraityte1, Lars Gullestad2, Erik Tandberg Askevold3, Ståle Nymo4, Christen P Dahl5, Sven Aakhus2, Pål Aukrust6, Thor Ueland7.   

Abstract

Entities:  

Keywords:  Aortic stenosis; DLL1; Notch signaling

Mesh：

Substances：

Year:  2014        PMID： 25438200     DOI： 10.1016/j.ijcard.2014.11.111

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.

Authors:  Michel Pompeu Barros de Oliveira Sá; Luiz Rafael P Cavalcanti; Álvaro M Perazzo; Rafael A F Gomes; Marie-Annick Clavel; Philippe Pibarot; Giuseppe Biondi-Zoccai; Konstantin Zhigalov; Alexander Weymann; Arjang Ruhparwar; Ricardo Carvalho Lima
Journal:  Curr Atheroscler Rep       Date:  2020-01-07       Impact factor: 5.113

2.  Notch Activation Associated with Poor Outcomes in Heart Failure: Is it Harmful, or not Enough of a Good Thing?

Authors:  Aditi Chiplunkar; Stacey Rentschler
Journal:  J Card Fail       Date:  2016-01-14       Impact factor: 5.712

3.  Host-Derived Delta-Like Canonical Notch Ligand 1 as a Novel Diagnostic Biomarker for Bacterial Sepsis-Results From a Combinational Secondary Analysis.

Authors:  Dagmar Hildebrand; Sebastian O Decker; Christian Koch; Felix C F Schmitt; Sophie Ruhrmann; Emmanuel Schneck; Michael Sander; Markus Alexander Weigand; Thorsten Brenner; Klaus Heeg; Florian Uhle
Journal:  Front Cell Infect Microbiol       Date:  2019-07-23       Impact factor: 5.293

Review 4.  Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview.

Authors:  Maria Bogdanova; Arsenii Zabirnyk; Anna Malashicheva; Daria Semenova; John-Peder Escobar Kvitting; Mari-Liis Kaljusto; Maria Del Mar Perez; Anna Kostareva; Kåre-Olav Stensløkken; Gareth J Sullivan; Arkady Rutkovskiy; Jarle Vaage
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.